Charlene A. Friedman

Charlene A. Friedman appears in our data through filings on MAP Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 14 April 2010 to 1 March 2013, the count stands at 19 filings.

On the market, this insider has only sold: 6 sales, €435k in total. Outside the open market, there are 3 share grants and 9 option exercises.

On 4 March 2013 came the latest disclosure, a transaction for €81k in MAP Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.